Antidepressants and antipsychotics classified with torsades de pointes arrhythmia risk and mortality in older adults ‐ a Swedish nationwide study
- 11 January 2016
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 81 (4) , 773-783
Abstract
Aim: The aim of the study was to examine mortality risk associated with use of antidepressants and antipsychotics classified with torsades de pointes (TdP) risk in elderly.Methods: A matched case–control register study was conducted in people 65 years and older dying outside hospital from 2008–2013 (n = 286 092) and matched controls (n = 1 430 460). The association between prescription of antidepressants and antipsychotics with various TdP risk according to CredibleMeds (www.crediblemeds.org) and all‐cause mortality was studied by multivariate conditional logistic regression adjusted for comorbidity and several other confounders.Results: Use of antidepressants classified with known or possible TdP risk, was associated with higher adjusted risk for mortality (OR 1.53, 95% CI 1.51, 1.56 and OR 1.63, 95% CI 1.61, 1.67, respectively) compared with antidepressants classified with conditional TdP risk (OR 1.25, 95% CI 1.22, 1.28) or without TdP classification (OR 0.99, 95% CI 0.94, 1.05). Antipsychotics classified with known TdP risk were associated with higher risk (OR 4.57, 95% CI 4.37, 4.78) than antipsychotics with possible risk (OR 2.58, 95% CI 2.52, 2.64) or without TdP classification (OR 2.14, 95% CI 2.03, 2.65). The following risk ranking was observed for commonly used antidepressants: mirtazapine > citalopram > sertraline > amitriptyline and for antipsychotics: haloperidol > risperidone >olanzapine > quetiapine.Conclusion: The CredibleMeds system predicted drug‐associated risk for mortality in the elderly at the risk class level. Among antipsychotics, haloperidol, and among antidepressants, mirtazapine and citalopram, were associated with the highest risks. The results suggest that the TdP risk with antidepressants and antipsychotics should be taken into consideration when prescribing to the elderly.Keywords
This publication has 44 references indexed in Scilit:
- Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal AnalysisPLOS ONE, 2013
- Predictive model for L‐type channel inhibition: multichannel block in QT prolongation risk assessmentJournal of Applied Toxicology, 2012
- Antidepressants and the risk of sudden cardiac death and ventricular arrhythmiaPharmacoepidemiology and Drug Safety, 2011
- External review and validation of the Swedish national inpatient registerBMC Public Health, 2011
- Sudden death in patients receiving drugs tending to prolong the QT intervalBritish Journal of Clinical Pharmacology, 2009
- Drug‐induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System (AERS)Pharmacoepidemiology and Drug Safety, 2009
- Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac DeathNew England Journal of Medicine, 2009
- Sudden cardiac death secondary to antidepressant and antipsychotic drugsExpert Opinion on Drug Safety, 2008
- The new Swedish Prescribed Drug Register—Opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiology and Drug Safety, 2006
- Tricyclic Antidepressant PoisoningToxicological Reviews, 2005